Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome

被引:103
作者
SivaSai, KSR
Smith, MA
Poindexter, NJ
Sundaresan, SR
Trulock, EP
Lynch, JP
Cooper, JD
Patterson, GA
Mohanakumar, T
机构
[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Cardiothorac Surg, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pulm Med, St Louis, MO 63110 USA
关键词
D O I
10.1097/00007890-199904270-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background The presentation of donor MHC class II-derived peptides by host antigen-presenting cells in the context of self-MHC class II molecules has been suggested as a mechanism for the chronic rejection of kidney and heart allografts. The aim of this study was 60 determine whether indirect allorecognition of HLA class I-derived peptides occurred in lung transplant (LTx) recipients and whether it correlated with the development of bronchiolitis obliterans syndrome (BOS). Methods. Peripheral blood mononuclear cells from LTx recipients were cultured with synthetic peptides corresponding to the hypervariable regions of the mismatched HLA class I antigens of the donor. Proliferation and precursor frequency (PF) of allopeptide reactive T cells were determined by the incorporation of [H-3]thymidine into DNA and limiting dilution analysis. Results. Peripheral blood leukocytes of LTx recipients with BOS mismatched for HLA class I molecules showed a proliferative response three- to fourfold higher than those observed in mismatched recipients without EOS and in normal control individuals (P < 0.001). Similarly, the PF of allopeptide-reactive T cell was 3- to 24-fold higher in recipients with BOS compared with recipients without BOS (P < 0.05) as well as normal control individuals (P < 0.03). The T cell PF 60 donor-specific allopeptides, as well as irrelevant allopeptides, was not significantly different in LTx recipients without BOS and normal control individuals. Conclusions. These data suggest that T cells from LTx recipients are sensitized to mismatched HLA class I antigens, The sensitization was significantly higher in LTx recipients with BOS compared with LTx recipients without BOS. Strategies to block T-cell responses generated by indirect allorecognition after lung transplantation may provide a means for the prevention or treatment of BOS in LTx recipients.
引用
收藏
页码:1094 / 1098
页数:5
相关论文
共 38 条
  • [1] THE ROLE OF INDIRECT RECOGNITION IN INITIATING REJECTION OF SKIN-GRAFTS FROM MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-DEFICIENT MICE
    AUCHINCLOSS, H
    LEE, R
    SHEA, S
    MARKOWITZ, JS
    GRUSBY, MJ
    GLIMCHER, LH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3373 - 3377
  • [2] INDIRECT T-CELL ALLORECOGNITION OF DONOR ANTIGENS CONTRIBUTES TO THE REJECTION OF VASCULARIZED KIDNEY ALLOGRAFTS
    BENHAM, AM
    SAWYER, GJ
    FABRE, JW
    [J]. TRANSPLANTATION, 1995, 59 (07) : 1028 - 1032
  • [3] DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION
    BENICHOU, G
    TAKIZAWA, PA
    OLSON, CA
    MCMILLAN, M
    SERCARZ, EE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 305 - 308
  • [4] Indirect T-cell allorecognition: Perspectives for peptide-based therapy in transplantation
    Benichou, G
    Tam, RC
    Soares, LRB
    Fedoseyeva, EV
    [J]. IMMUNOLOGY TODAY, 1997, 18 (02): : 67 - 71
  • [5] Bradley J A, 1996, Int Rev Immunol, V13, P245, DOI 10.3109/08830189609061751
  • [6] CYTOTOXIC T-CELL RECOGNITION OF AN ENDOGENOUS CLASS-I HLA PEPTIDE PRESENTED BY A CLASS-II HLA MOLECULE
    CHEN, BP
    MADRIGAL, A
    PARHAM, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) : 779 - 788
  • [7] COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713
  • [8] DUNCAN AJ, 1991, J HEART LUNG TRANSPL, V10, P638
  • [9] CORECOGNITION OF HLA-A1 AND HLA-DPW3 BY A HUMAN CD4+ ALLOREACTIVE LYMPHOCYTE-T CLONE
    ESSAKET, S
    FABRON, J
    DEPREVAL, C
    THOMSEN, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) : 387 - 390
  • [10] REJECTION OF SKIN ALLOGRAFTS BY INDIRECT ALLORECOGNITION OF DONOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES
    FANGMANN, J
    DALCHAU, R
    FABRE, JW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) : 1521 - 1529